Laryngeal edema following remimazolam-induced anaphylaxis: a rare clinical manifestation

Abstract Background Remimazolam is an ultra-short-acting intravenous benzodiazepine, which has been used as sedative/anesthetic in procedural sedation and anesthesia. Although peri-operative anaphylaxis due to remimazolam has been reported recently, the spectrum of the allergic reactions is still no...

Full description

Bibliographic Details
Main Authors: Xiawei Hu, Yaning Tang, Xiangming Fang
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Anesthesiology
Subjects:
Online Access:https://doi.org/10.1186/s12871-023-02052-w

Similar Items